WBA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
WBA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2024-10-31), Walgreens Boots Alliance's Intrinsic Value: Projected FCF is $38.87. The stock price of Walgreens Boots Alliance is $9.46. Therefore, Walgreens Boots Alliance's Price-to-Intrinsic-Value-Projected-FCF of today is 0.2.
The historical rank and industry rank for Walgreens Boots Alliance's Intrinsic Value: Projected FCF or its related term are showing as below:
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Walgreens Boots Alliance was 1.72. The lowest was 0.23. And the median was 0.59.
The historical data trend for Walgreens Boots Alliance's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Walgreens Boots Alliance Annual Data | |||||||||||||||||||||
Trend | Aug15 | Aug16 | Aug17 | Aug18 | Aug19 | Aug20 | Aug21 | Aug22 | Aug23 | Aug24 | |||||||||||
Intrinsic Value: Projected FCF | Get a 7-Day Free Trial | 82.97 | 83.03 | 77.60 | 59.05 | 38.87 |
Walgreens Boots Alliance Quarterly Data | ||||||||||||||||||||
Nov19 | Feb20 | May20 | Aug20 | Nov20 | Feb21 | May21 | Aug21 | Nov21 | Feb22 | May22 | Aug22 | Nov22 | Feb23 | May23 | Aug23 | Nov23 | Feb24 | May24 | Aug24 | |
Intrinsic Value: Projected FCF | Get a 7-Day Free Trial | 59.05 | 54.41 | 46.03 | 43.27 | 38.87 |
For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Walgreens Boots Alliance's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)
In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):
Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)
Add all the Free Cash Flow together and divide 6 will get Walgreens Boots Alliance's Free Cash Flow(6 year avg) = $2,648.64.
Walgreens Boots Alliance's Intrinsic Value: Projected FCF for today is calculated as
Intrinsic Value: Projected FCF | = | (Growth Multiple | * | Free Cash Flow (6 year avg) | + | Total Stockholders Equity (Aug24) | * | 0.8) | / | Shares Outstanding (Diluted Average) |
= | (9.5203515959648 | * | 2648.64 | + | 10446 | * | 0.8) | / | 863.700 | |
= | 38.87 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Walgreens Boots Alliance (NAS:WBA) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Walgreens Boots Alliance's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF | = | Share Price | / | Intrinsic Value: Projected FCF |
= | 9.46 | / | 38.870885783416 | |
= | 0.24 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Walgreens Boots Alliance's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Inderpal S Bhandari | director | C/O WALGREENS BOOTS ALLIANCE, INC., DEERFIELD IL 60015 |
Manmohan Mahajan | officer: SVP, Global Controller and CAO | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Nancy M Schlichting | director | 200 WILMOT ROAD, DEERFIELD IL 60015 |
Timothy C Wentworth | director, officer: Chief Executive Officer | C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121 |
Richard P. Gates | officer: SVP, Chief Pharmacy Officer | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Neal J. Sample | officer: EVP, Chief Information Officer | 200 VESEY STREET, NEW YORK NY 10285 |
Todd Heckman | officer: Interim Global Controller | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Polen Thomas E Jr | director | BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
John Patrick Driscoll | officer: EVP, Pres. U.S. Healthcare | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Rosalind G Brewer | director, officer: CEO | C/O MOLSON COORS BREWING COMPANY, 1225 17TH STREET, SUITE 3200, DENVER CO 80202 |
Kevin M. Ban | officer: EVP, Chief Medical Officer | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Bryan C Hanson | director | ZIMMER BIOMET HOLDINGS, 345 E. MAIN STREET, WARSAW IN 46580 |
Henry Lee Cooper | officer: EVP, Pres. Walgreens Pharmacy | C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015 |
Tracey D Brown | officer: SVP, Pres., Walgreens Retail | 675 AVENUE OF THE AMERICAS, 6TH FLOOR, NEW YORK NY 10010 |
Steven J Shulman | director | 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329 |
From GuruFocus
By Business Wire • 09-25-2024
By Marketwired • 09-19-2024
By Marketwired • 09-04-2024
By Business Wire • 09-09-2024
By PRNewswire • 09-06-2024
By Business Wire • 09-09-2024
By PRNewswire • 09-05-2024
By PRNewswire • 09-03-2024
By PRNewswire • 09-08-2024
By Business Wire • 09-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.